Cerity Partners
GH icon

Cerity Partners’s Guardant Health GH Stock Holding History

Cerity Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Sell
109,250
-8,746
-7% -$878K 0.01% 687
2025
Q4 		$12.1M Sell
117,996
-12,981
-10% -$1.16M 0.02% 569
2025
Q3 		$8.18M Sell
130,977
-13,404
-9% -$729K 0.01% 660
2025
Q2 		$7.51M Sell
144,381
-1,094
-0.8% -$48.9K 0.01% 644
2025
Q1 		$6.2M Buy
145,475
+8,725
+6% +$376K 0.01% 658
2024
Q4 		$3.27M Sell
136,750
-58,258
-30% -$1.64M 0.01% 892
2024
Q3 		$4.47M Buy
195,008
+68,883
+55% +$1.95M 0.01% 736
2024
Q2 		$3.64M Sell
126,125
-62,334
-33% -$1.45M 0.01% 707
2024
Q1 		$3.89M Buy
188,459
+138,817
+280% +$2.98M 0.01% 734
2023
Q4 		$1.34M Buy
49,642
+34,388
+225% +$902K ﹤0.01% 895
2023
Q3 		$452K Sell
15,254
-46,258
-75% -$1.63M ﹤0.01% 1016
2023
Q2 		$2.2M Buy
61,512
+17,266
+39% +$496K 0.01% 699
2023
Q1 		$1.04M Buy
44,246
+13,178
+42% +$376K ﹤0.01% 957
2022
Q4 		$845K Buy
31,068
+9,435
+44% +$432K 0.01% 744
2022
Q3 		$1.17M Buy
21,633
+6,317
+41% +$324K 0.01% 476
2022
Q2 		$618K Sell
15,316
-1,636
-10% -$81.1K 0.01% 679
2022
Q1 		$1.12M Buy
16,952
+1,519
+10% +$104K 0.02% 424
2021
Q4 		$1.54M Buy
15,433
+186
+1% +$19.2K 0.02% 359
2021
Q3 		$1.91M Buy
15,247
+113
+0.7% +$13.4K 0.04% 270
2021
Q2 		$1.88M Buy
15,134
+122
+0.8% +$16.4K 0.04% 276
2021
Q1 		$2.29M Buy
15,012
+563
+4% +$85.1K 0.05% 234
2020
Q4 		$1.86M Sell
14,449
-338
-2% -$38.9K 0.06% 226
2020
Q3 		$1.65M Buy
+14,787
New +$1.35M 0.07% 191
2019
Q2 		– Sell
-13,279
Closed -$1.02M – 521
2019
Q1 		$1.02M Buy
+13,279
New +$736K 0.07% 232

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners's GH Position: Q1 2026 in Review

Cerity Partners reduced its Guardant Health (GH) stake by 7.4% in Q1 2026, selling an estimated $878K and leaving 109,250 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #687.

Cerity Partners first reported a position in GH in Q1 2019 and has held it in 24 quarters since. The position peaked at $12.1M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Cerity Partners held 109,250 shares of Guardant Health worth $10.1M as of Q1 2026.
  • Cerity Partners sold 8,746 Guardant Health shares in Q1 2026, an estimated $878K.
  • Guardant Health made up 0.01% of Cerity Partners's portfolio in Q1 2026, its #687 holding.
  • Cerity Partners first reported a position in Guardant Health in Q1 2019 and has held it in 24 quarters since.
  • Cerity Partners's Guardant Health position peaked at $12.1M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.